MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 20, 2004; DOI: 10.1124/mol.104.008409


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.008409v1
67/3/766    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanayama, T.
Right arrow Articles by Nishikawa, J.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanayama, T.
Right arrow Articles by Nishikawa, J.-i.


Received for publication October 19, 2004.
Revised December 18, 2004.
Accepted for publication December 20, 2004.

Organotin compounds promote adipocute differentiation as agonists of the peroxisome proliferator-activated receptor (PPAR) {gamma} / retinoid X receptor (RXR) pathway

Tomohiko Kanayama 1, Naoki Kobayashi 1, Satoru Mamiya 1, Tsuyoshi Nakanishi 1, Jun-ichi Nishikawa 1*

1 Osaka University

* Address correspondence to: E-mail: nisikawa{at}phs.osaka-u.ac.jp

Abstract

Nuclear receptors play important roles in the maintenance of the endocrine system, regulation of organ differentiation, and fetal development. Endocrine disruptors exert their adverse effects by disrupting the endocrine system via various mechanisms. To assess the effects of endocrine disruptors on nuclear receptors, we developed a high-throughput method for identifying activators of nuclear receptors. Using this system, we found that triphenyltin and tributyltin were activators of peroxisome proliferators-activated receptor (PPAR) {gamma} and retinoid X receptor. Because PPAR{gamma} is a master regulator of adipocyte differentiation, we assessed the effect of organotin compounds on preadipocyte, 3T3-L1 cells. We found that organotin compounds stimulated differentiation of 3T3-L1 cells as well as expression of adipocyte marker genes.


Key words: Sex hormones, PPARs, Receptor binding studies, Regulation - transcriptional, Protein targets, Cholesterol metabolism/lipoproteins


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. N. Feige, L. Gelman, D. Rossi, V. Zoete, R. Metivier, C. Tudor, S. I. Anghel, A. Grosdidier, C. Lathion, Y. Engelborghs, et al.
The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor {gamma} Modulator That Promotes Adipogenesis
J. Biol. Chem., June 29, 2007; 282(26): 19152 - 19166.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
L Dubuquoy, C Rousseaux, X Thuru, L Peyrin-Biroulet, O Romano, P Chavatte, M Chamaillard, and P Desreumaux
PPAR{gamma} as a new therapeutic target in inflammatory bowel diseases.
Gut, September 1, 2006; 55(9): 1341 - 1349.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. Grun, H. Watanabe, Z. Zamanian, L. Maeda, K. Arima, R. Cubacha, D. M. Gardiner, J. Kanno, T. Iguchi, and B. Blumberg
Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates
Mol. Endocrinol., September 1, 2006; 20(9): 2141 - 2155.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Grun and B. Blumberg
Environmental Obesogens: Organotins and Endocrine Disruption via Nuclear Receptor Signaling
Endocrinology, June 1, 2006; 147(6): s50 - s55.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. M. Tabb and B. Blumberg
New Modes of Action for Endocrine-Disrupting Chemicals
Mol. Endocrinol., March 1, 2006; 20(3): 475 - 482.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics